Literature DB >> 30571276

Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease?

Teneema Kuriakose1, Thirumala-Devi Kanneganti1.   

Abstract

Entities:  

Keywords:  Editorials; IL-1β; acute rheumatic fever; group A streptococcus; hydroxychloroquine; inflammasomes; rheumatic heart disease

Mesh：

Substances：

Year:  2018        PMID： 30571276      PMCID： PMC6317860          DOI： 10.1161/CIRCULATIONAHA.118.036771

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine.

Authors:  Man Lyang Kim; William J Martin; Gabriela Minigo; Joanne L Keeble; Alexandra L Garnham; Guido Pacini; Gordon K Smyth; Terence P Speed; Jonathan Carapetis; Ian P Wicks
Journal:  Circulation       Date:  2018-12-04       Impact factor: 29.690

Review 2.  Targeting the NLRP3 inflammasome in inflammatory diseases.

Authors:  Matthew S J Mangan; Edward J Olhava; William R Roush; H Martin Seidel; Gary D Glick; Eicke Latz
Journal:  Nat Rev Drug Discov       Date:  2018-07-20       Impact factor: 84.694

Review 3.  Acute rheumatic fever.

Authors:  Ganesan Karthikeyan; Luiza Guilherme
Journal:  Lancet       Date:  2018-06-29       Impact factor: 79.321

Review 4.  Inflammasomes and autoimmunity.

Authors:  Patrick J Shaw; Michael F McDermott; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2010-12-14       Impact factor: 11.951

5.  Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.

Authors:  Anette Christ; Patrick Günther; Mario A R Lauterbach; Peter Duewell; Debjani Biswas; Karin Pelka; Claus J Scholz; Marije Oosting; Kristian Haendler; Kevin Baßler; Kathrin Klee; Jonas Schulte-Schrepping; Thomas Ulas; Simone J C F M Moorlag; Vinod Kumar; Min Hi Park; Leo A B Joosten; Laszlo A Groh; Niels P Riksen; Terje Espevik; Andreas Schlitzer; Yang Li; Michael L Fitzgerald; Mihai G Netea; Joachim L Schultze; Eicke Latz
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

Review 6.  The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation.

Authors:  Deepika Sharma; Thirumala-Devi Kanneganti
Journal:  J Cell Biol       Date:  2016-06-20       Impact factor: 10.539

7.  Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation.

Authors:  Tao-Tao Tang; Lin-Li Lv; Ming-Ming Pan; Yi Wen; Bin Wang; Zuo-Lin Li; Min Wu; Feng-Mei Wang; Steve D Crowley; Bi-Cheng Liu
Journal:  Cell Death Dis       Date:  2018-03-02       Impact factor: 8.469

Review 8.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

Review 9.  Inflammasome/IL-1β Responses to Streptococcal Pathogens.

Authors:  Christopher N LaRock; Victor Nizet
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

Review 10.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561
View more
  2 in total

1.  Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils.

Authors:  Yuya Fujita; Naoki Matsuoka; Jumpei Temmoku; Makiko Yashiro Furuya; Tomoyuki Asano; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Eiji Suzuki; Takeshi Urano; Hideko Kozuru; Hiroshi Yatsuhashi; Tomohiro Koga; Atsushi Kawakami; Kiyoshi Migita
Journal:  Arthritis Res Ther       Date:  2019-11-27       Impact factor: 5.156

Review 2.  The Genetic Control of the Rheumatic Heart: Closing the Genotype-Phenotype Gap.

Authors:  Atiyeh M Abdallah; Marawan Abu-Madi
Journal:  Front Med (Lausanne)       Date:  2021-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.